Digitalization of the HYPOGLYRISK and Evaluation Its Utility for Pharmacists in Assessing the Risk of Severe Hypoglycemia in Ambulatory T2DM Patients Compared to Their Printed Version.
Penulis/Author
MADE KRISNA ADI JAYA (1); Dr. apt. Fita Rahmawati, Sp.FRS. (2); Dr. apt. Nanang Munif Yasin, S.Si., M.Pharm. (3); Prof. Dr. apt. Zullies Ikawati. (4)
Tanggal/Date
2025
Kata Kunci/Keyword
Abstrak/Abstract
We created tools for pharmacists to facilitate the screening of medication-related hypoglycemia risk in T2DM patients named HYPOGLYRISK. This instrument was reported to be valid and reliable. The pharmacist’s deployment of HYPOGLYRISK revealed issues with limited screening duration, thus necessitating the immediate modification of the equipment into a digital format. This study aims to remake HYPOGLYRISK into a digital form to assess its efficacy relative to the printed version. This study went through two stages. The first stage was the development of the application and its validation, while the second stage was the trial stage using a quasi-experimental study design. A total of 46 pharmacists were involved in the study. The digital HYPOGLYRISK was successfully produced and deemed valid in the Black Box and User Acceptance Test. The digital HYPOGLYRISK was shown to be more efficient based on the duration of the patient's assessment time compared to their printed version (p<0.05). The usage of digital HYPOGLYRISK also reduced the probability of human error by 3.3 times compared to the paper version (p<0.05). The digital version of HYPOGLYRISK gave pharmacists more benefits, such as efficiency, scalability, easy user adaptability, reduced human error, rapid data access, simple data management, and integration.
